Lavage administration of dilute recombinant surfactant in acute lung injury in piglets

Pediatric Research

Volumn 47, Issue 2, 2000, Pages 240-245

  Meister, Joan C ^a   Balaraman, Venkataraman ^a   Ku, Tercia ^b   DeSilva, Asoka ^b   Sood, Sneha ^a   Uyehara, Catherine F T ^b   Person, Donald A ^b   Easa, David ^a  

^a KAPIOLANI MEDICAL CENTER FOR WOMEN AND CHILDREN   (United States)

^b Kapiolani Medical Center Women C ^*

Author keywords

[No Author keywords available]

Indexed keywords

LUNG SURFACTANT; PHOSPHOLIPID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTERIAL CARBON DIOXIDE TENSION; ARTERIAL OXYGEN TENSION; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; FEMALE; FUNCTIONAL RESIDUAL CAPACITY; LUNG COMPLIANCE; LUNG INJURY; LUNG INSUFFICIENCY; LUNG LAVAGE; MALE; NONHUMAN; PRIORITY JOURNAL; SWINE;

EID: 0033959398     PISSN: 00313998     EISSN: None     Source Type: Journal    
DOI: 10.1203/00006450-200002000-00015     Document Type: Article

References (23)

1. Evans D, Wilmott R, Whitsett J 1996 Surfactant replacement therapy for adult respiratory distress syndrome in children. Pediatr Pulmonol 21:328-336
2. Hartog A, Gommers D, Lachmann B 1995 Role of surfactant in the pathophysiology of the acute respiratory distress syndrome (ARDS). Monaldi Arch Chest Dis 50:372-377
3. Jobe AH, Ikegami M 1997 The future of surfactant replacement therapy. In: Frantz I (ed) Neonatal Respiratory Diseases, Vol 7. no 4. Tufts University School of Medicine, Medical Marketing Co. Inc, Newtown, PA
4. Ueda T, Ikegami M, Rider E, Jobe A 1994 Distribution of surfactant and ventilation in surfactant-treated preterm lambs. J Appl Physiol 76:45-55
5. Walmrath D, Gunther A, Ghofrani H, Schermully R, Schneider T, Grimminger F, Seeger W 1996 Bronchoscopic surfactant administration in patients with severe adult respiratory distress syndrome and sepsis. Am J Respir Crit Care Med 154:57-62
6. Balaraman V, Meister JC, Ku T, Sood S, Uyehara C, Easa D 1998 Lavage administration of dilute surfactants after acute lung injury in neonatal piglets. Am J Respir Crit Care Med 158:12-17
7. Balaraman V, Sood SL, Finn KL, Hashiro G, Uyehara C, Easa D 1996 Physiologic response and lung distribution of lavage versus bolus Exosurf in piglets with acute lung injury. Am J Respir Crit Care Med 153:1838-1843
8. Meister JC, Balaraman V, Ku T, Sood SL, Uyehara C, Easa D 1997 Is there an advantage to lavage administration of exogenous surfactant after nonhomogeneous lung injury in neonatal piglets? Am J Respir Crit Care Med 155:393A(abstr)
9. Hafner D, Germann PG, Hauschke D 1994 Effects of lung surfactant factor (LSF) treatment on gas exchange and histopathological changes in an animal model of adult respiratory distress syndrome (ARDS): comparison of recombinant LSF with bovine LSF. Pulm Pharmacol 7:319-332
10. Henry M, Rebello C, Ikegami M, Jobe AH, Langenback E, Davis J 1996 Ultrasonic nebulized in comparison with instilled surfactant treatment of preterm lambs. Am J Respir Crit Care Med 154:366-375
11. Jobe AH, Ikegami M, Jacobs H, Jones S 1984 Surfactant and pulmonary blood flow distributions following treatment of premature lambs with natural surfactant. J Clin Invest 73:848-856
12. Robertson B 1991 Surfactant inactivation and surfactant replacement in experimental models of ARDS. Acta Anaesthsiol Scand 35(suppl):22-28
13. Notter RH, Egan EA, Kwong MA, Holm BA, Shapiro DL 1985 Lung surfactant replacement in premature lambs with extracted lipids from bovine lung lavage: effects of dose, dispersion technique, and gestational age. Pediatr Res 19:569-577
14. Lewis J, Ikegami M, Jobe A, Absolom D 1993 Physiologic responses and distribution of aerosolized surfactant (Survanta) in a nonuniform pattern of lung injury. Am Rev Respir Dis 147:1364-1370
15. Zelter M, Escudier BJ, Hoeffel JM, Murray JF 1990 Effects of aerosolized artificial surfactant on repeated oleic acid injury in sheep. Am Rev Respir Dis 141:1014-1019
16. Anzueto A, Baughman R, Guntupalli K, Weg J, Wiedemann H, Raventos A, Lemaire F, Long W, Zaccardelli S, Pattishall E 1996 Aerosolized surfactant in adults with sepsis-induced ARDS. N Engl J Med 334:1417-1421
17. Gilliard N, Richman PM, Merritt TA, Spragg RG 1990 Effect of volume and dose on the pulmonary distribution of exogenous surfactant administered to normal rabbits or to rabbits with oleic acid injury. Am Rev Respir Dis 141:743-747
18. Oetomo SB, Lewis J, Ikegami M, Jobe AH 1990 Surfactant treatments after endogenous surfactant metabolism in rabbit lungs. J Appl Physiol 68:1590-1596
19. VanderBleek J, Plotz F, Overbeek F, Heikamp H, Beekhuis C, Wildevuur R, Okken A, Oetomo S 1993 Distribution of exogenous surfactant in rabbits with severe respiratory failure: the effect of volume. Pediatr Res 34:154-158
20. Jobe AH 1995 Techniques for administering surfactant. In: Robertson B, Tacusch HW (eds) Surfactant Therapy for Lung Disease. Marcel Dekker, New York, pp 309-324
21. Simonson SG, Huang YC, Fracica PJ, Sane AC, Piantadosi CA, Young SL 1992 Exogenous surfactant improves oxygenation in hyperoxic lung injury. Am Rev Respir Dis 145:610A(abstr)
22. Davis A, Jobe A, Hafner D, Ikegami M 1998 Lung function in premature lambs and rabbits treated with a recombinant SP-C surfactant. Am J Respir Crit Care Med 157:553-559
23. Ikegami M, Jobe A 1998 Surfactant protein-C in ventilated premature lamb lung. Pediatr Res 44:860-864